Detalhe da pesquisa
1.
Population Pharmacodynamic Modelling of the CD19+ Suppression Effects of Rituximab in Paediatric Patients with Neurological and Autoimmune Diseases.
Pharmaceutics
; 15(11)2023 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38004515